Skip to content
Screener

Insmed INSM Asset turnover

Asset turnover at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
0.7×
United Therapeutics logo
United TherapeuticsUTHR
0.4×0.0×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
0.7×+0.1×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×
Theravance Biopharma logo
Theravance BiopharmaTBPH
0.3×+0.1×
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$21.37B+1.1%
Enterprise value$21.37B+4.6%
P/S26.1×-27.0×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Calculated from Insmed’s reported figures.

Based on trailing twelve months.

The source filing: Insmed’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104506-26-000032

FAQ

What is Insmed's asset turnover?
Insmed (INSM) reported asset turnover of 0.4× in Q1 2026.
How has Insmed's asset turnover changed year-over-year?
Insmed's asset turnover increased by 64.2% year-over-year, from 0.3× to 0.4×.
What is the long-term trend for Insmed's asset turnover?
Over 5 years (2020 to 2025), Insmed's asset turnover has grown at a 5.8% compound annual growth rate (CAGR), from 0.2× to 0.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Insmed's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude